New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
AstraZeneca (AZN)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
Key Metrics for AZN as compared to
Top Competitors
Drug Manufacturers - Major
Drug Manufacturers
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INCOME STATEMENT (
See all
)
Revenue
►
27.0B
EBITDA
►
10.3B
Net Income
►
5.67B
Revenue Growth
►
11.5%
Net Income Growth
►
-14.2%
Operating Margin
►
23.8%
Net Margin
►
21%
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
Please install
Flash Player
to view this chart.
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
1.35
Current Ratio
►
1.32
Quick Ratio
►
1.18
Interest Coverage Ratio
►
10.7
Book Value Per Share
►
17.8
Cash Per Share
►
5.79
ASSETS
LIABILITIES
Cash
7.23B
Current Liabilities
13.9B
Other Current Assets
11.1B
Long-term Debt
9.32B
Fixed Assets
5.88B
Other Liabilities
6.66B
Other Assets
28.1B
Total Liabilities
30.0B
Total Assets
52.3B
Total Equity
22.3B
INDUSTRY METRICS (
See all
|
Compare across Drug Manufacturers
)
Revenue
►
27.0B
Revenue
Net Income
Operating Income
SEC FILINGS (
See all
)
Form 3 (Oct 12)
Older:
10/12/12
,
05/01/12
View All Filings for AstraZeneca (AZN)
STOCK SUMMARY
Open
Day Range
-
52 Week Range
-
Volume
Avg Volume (3 mo)
Shares Outstanding
1250000000.00000
Market Cap
EPS
4.54
VALUATION
Price to Earnings (P/E)
►
11.4
Price to Book (P/B)
►
2.89
Price to Sales (P/S)
►
2.38
Return on Assets (ROA)
►
12.4%
Return on Equity (ROE)
►
25.9%
EV/EBITDA
►
6.93
Dividend Yield
7.4%
ANALYST RECOMMENDATIONS
Please install
Flash Player
to view this chart.
OWNERSHIP
Held by institutions
0%
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour